COROMANDEL INTERNATIONAL LTD.

Coromandel International Limited announced the reappointment of Mr. Sudarshan Venu as an Independent Director for a second term of five years, effective February 3, 2027, through February 2, 2032. This reappointment is subject to shareholder approval via postal ballot. The Board also approved the unaudited financial results for the quarter and half-year ended September 30, 2026, along with the limited review report. Additionally, the conversion of a USD 9.70 Million loan into equity for its step-down subsidiary, Baobab Mining and Chemicals Corporation S.A. (BMCC), has been completed.

Coromandel International Limited's Board of Directors convened on November 6, 2026, approving the unaudited financial results for the quarter and half-year ended September 30, 2026. The results, along with the Limited Review Report from S R Batliboi & Associates LLP, will be uploaded to the company and stock exchange websites. Additionally, the Board approved the re-appointment of Mr. Sudarshan Venu as an Independent Director for a second five-year term, commencing February 3, 2027, subject to shareholder approval via postal ballot. The company also noted the completion of a USD 9.70 Million loan-to-equity conversion for its step-down subsidiary, Baobab Mining and Chemicals Corporation S A (BMCC).

Coromandel International Limited's Board of Directors, in a meeting held on November 6, 2026, approved the unaudited financial results for the quarter and half-year ended September 30, 2026. The results are available on standalone and consolidated bases and were accompanied by a Limited Review Report from statutory auditors M/s. S R Batliboi & Associates LLP. The Board also approved the re-appointment of Mr. Sudarshan Venu as an Independent Director for a second five-year term, subject to shareholder approval. Additionally, the conversion of a USD 9.70 Million loan into equity for step-down subsidiary Baobab Mining and Chemicals Corporation S A (BMCC) has been completed.

Coromandel International's consolidated PAT fell 34% YoY to ₹523 Cr (from ₹793 Cr) even as revenue grew 6.6% YoY to ₹10,294 Cr, pulling net margin down to 5.1% from 8.1% a year ago. Sequentially PAT was up 37% QoQ (from ₹382 Cr) on 26% QoQ revenue growth, but that is the usual H2 seasonal ramp for a fertiliser business and does not offset the YoY softness. Standalone told the same story — PAT ₹548 Cr, down 33% YoY — so there is no standalone/consolidated divergence to flag; consolidated is the primary read. The pressure sat squarely in the Nutrient and allied segment, which is ~88% of revenue: segment EBIT fell 24% YoY to ₹746 Cr even as segment revenue rose 4.4% YoY to ₹9,042 Cr, implying real margin compression as an erratic, excess-rainfall end to the kharif season curbed offtake. Crop Protection EBIT was roughly flat to down (₹130 Cr vs ₹145 Cr YoY) despite 22% revenue growth to ₹1,308 Cr — that revenue jump is largely inorganic, from NACL Industries' now full-quarter consolidation (a subsidiary only since August 2025), so the segment's underlying profitability actually diluted rather than scaled. Street positioning matters here: Nuvama's pre-results preview had flagged a steep 56% YoY EBITDA decline for Coromandel on monsoon-hit agri-input demand — one of the sharper cuts among peers it covered (PI Industries -37%, Rallis -27%, Sumitomo Chemical India -17%). Against that bar, a ~34% PAT decline and ~24% nutrient-EBIT decline is a beat on the bearish Street setup, even though it is still a YoY decline in absolute terms. On guidance, management's Q1 call target of lifting nutrient EBITDA/ton toward ₹6,500 isn't independently checkable from the disclosed line items this quarter, but the one guidance point that is directly verifiable — subsidy income booked at existing Kharif NBS rates pending the Rabi 2026-27 notification — remains exactly as flagged, per the company's own Note 5, with any true-up deferred to a later quarter. The quarter also saw the board convert a USD 9.7 million loan into equity in step-down subsidiary Baobab Mining and Chemicals (Senegal) and issue a fresh USD 15.5 million guarantee for a subsidiary, both consistent with management's stated backward-integration push into phosphate rock supply. Going into Q3, which covers the Rabi season, the key markers are whether nutrient segment margins recover from this quarter's compression and whether the pending Rabi NBS rate notification triggers any subsidy true-up against what was booked this quarter at Kharif rates.

Coromandel International Limited has announced that a meeting of its Board of Directors is scheduled for Friday, November 6, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026, on both standalone and consolidated bases. The company has formally informed the BSE and NSE about this upcoming board meeting.

Coromandel International Ltd has received an Order-in-Appeal from the Deputy Commissioner (Appeal), Chennai North, Tamil Nadu State GST, concerning FY 2019-20. The order confirms a demand of ₹1,78,56,068 in tax, ₹2,08,43,168 in interest, and ₹17,85,606 in penalty, totaling approximately ₹4.05 Crore. The demand is on account of alleged availment of ineligible Input Tax Credit. The company believes it has a strong case and intends to file an appeal before the GSTAT. Coromandel International stated that the order is not expected to have a significant impact on its financials, operations, or other activities.

Coromandel International Ltd has received an order from the Additional Commissioner, Central GST, Vadodara, for the financial years 2021-22 to 2024-25. The order pertains to alleged wrongful availment and utilization of Input Tax Credit (ITC), resulting in a tax demand of ₹2,50,82,496 (approximately ₹2.51 Crore) along with equivalent penalty and applicable interest. The company, however, believes it has a strong case and intends to appeal the order before the Commissioner (Appeals). Coromandel International stated that this demand is not expected to have a significant impact on its financials, operations, or other activities.

Coromandel International Ltd has announced the closure of its trading window for dealing in the company's securities. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ending September 30, 2026. This is a standard regulatory procedure to prevent potential insider trading during periods of sensitive financial information disclosure.

Coromandel International Ltd has received an Order-in-Appeal from the Additional Commissioner (Appeals), Jodhpur, for FY 2019-20. The order confirms a demand of Rs. 71,63,421/- plus a penalty of Rs. 12,66,303/- and applicable interest. The demand is primarily due to alleged excess availment of Input Tax Credit (ITC) stemming from a mismatch between GSTR-3B and GSTR-2A. The company disputes the findings and plans to appeal to the Goods and Services Tax Appellate Tribunal, stating no significant impact on its financials or operations.

Coromandel International Limited has issued a corporate guarantee of USD 15.5 million to Citibank N.A. This guarantee supports a working capital facility of USD 14.09 million for its subsidiary, Baobab Mining & Chemicals Corporation (BMCC) in Senegal. The transaction is considered at arm's length, with Coromandel Chemicals Limited, a wholly-owned subsidiary and part of the promoter group, holding investments in BMCC. The guarantee represents a contingent liability for Coromandel International, applicable if BMCC fails to repay the working capital facility.